Abstract: A connector to connect a center wing box to a bulkhead of an aircraft. The connector includes a panel with a first edge positioned at the center wing box, an opposing second edge positioned at the bulkhead, and a central section. A first flexible seal extends across the panel and provides for relative movement between the first edge and the central section. A second flexible seal extends across the panel and provides for relative movement between the second edge and the central section.

Abstract: The present disclosure generally relates to auditory nerve stimulation to create the perception of sound in the brain of a subject such as an animal or human being. In one form, a system includes an implantable electrode array including a plurality of spaced apart micro-needles. The system also includes a first electrical lead electrically coupled to and extending from the implantable electrode array, and an auditory signal device configured to produce one or more electrical signals representative of communications received from an external processor. An interposer is configured to electrically couple the implantable electrode array and the auditory signal device in an arrangement where one or more electrical signals produced by the auditory signal device may be transmitted through the first electrical lead to the implantable electrode array. Various novel stimulation strategies can be employed, such as place modulated stimulation signals.

Abstract: The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).

Abstract: Technology for automatic cross-device meeting authentication.

Abstract: The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).

Abstract: Technology for automatic cross-device meeting authentication.

Abstract: Persistent storage may contain a plurality of user interface (UI) component definitions. One or more processors may be configured to: receive, by way of a platform UI builder, selection of a UI component definition from the plurality of UI component definitions; bind, by way of input entered into the platform UI builder, data to the UI component definition, wherein the data is from a data source, and wherein the input is a programmatic statement that references the data source or a set of values that references the data source; generate, by way of the platform UI builder, metadata representing the input; create, by a platform runtime, a UI component that incorporates the data into the UI component definition in accordance with the metadata; generate, by the platform runtime, a graphical user interface including the UI component; and provide, for display on a client device, a representation of the graphical user interface.

Abstract: Technology for automatic cross-device meeting authentication. An example method involving initializing, by a first computing device, a real-time meeting communication session, wherein the first computing device is connected to a media system; receiving information indicative of a mobile computing device of a user being in a physical presence of the first computing device, wherein the user is associated with the mobile device and a second computing device; granting control of the real-time meeting communication session from the mobile computing device of the user to the first computing device; transmitting an instruction that causes the second computing device to display a user interface element associated with the real-time meeting communication session, wherein the instruction is sent after granting the control; and granting control of the real-time meeting communication session to the second computing device of the user in response to a selection of the user interface element.

Abstract: The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).

Abstract: The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).

Abstract: Technology for automatic cross-device meeting authentication. An example method involving initializing, by a first computing device, a real-time meeting communication session, wherein the first computing device is connected to a media system; receiving information indicative of a mobile computing device of a user being in a physical presence of the first computing device, wherein the user is associated with the mobile device and a second computing device; granting control of the real-time meeting communication session from the mobile computing device of the user to the first computing device; transmitting an instruction that causes the second computing device to display a user interface element associated with the real-time meeting communication session, wherein the instruction is sent after granting the control; and granting control of the real-time meeting communication session to the second computing device of the user in response to a selection of the user interface element.

Abstract: Computer-implemented techniques can include initializing, by a server and with a first computing device, a real-time communication session, wherein the first computing device is connected to a media system, receiving, from at least one of the first computing device and a mobile computing device, authentication information for a user associated with the mobile computing device, the authentication information being indicative of the mobile computing device being in short-range wireless communication with the first computing device, associating the user with the real-time communication session, detecting that a second computing device that is associated with the user is logged into a same account as the mobile computing device, and in response to the associating and the detecting, transmitting, to the second computing device, instructions that cause the second computing device to display a user interface element associated with the real-time communication session.

Abstract: The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).

Abstract: The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).

Abstract: This disclosure describes techniques in which one or more computing devices receive a signal from a first client computing device. The signal indicates that the first client computing device is available for participation in a communication session that enables communication between the first client computing device and one or more other client computing devices. The one or more computing devices determine a context for a topic of discussion associated with the communication session. The context is associated with a content item capable of being outputted by the first client computing device. Responsive to receiving the signal, the one or more computing devices initiate the communication session and send an invitation to at least one of the one or more other client computing devices to join the communication session. The invitation indicates the context of the communication session to at least one of the one or more other client computing devices.

Abstract: The invention relates to a novel group of compounds of Formula (I) or salts thereof: wherein Y, Z1, Z2, R1, R4, R5 and n are as described in the specification, which may be useful in the treatment or prevention of a disease or medical condition mediated through protein kinase B (PKB) such as cancer. The invention also relates to pharmaceutical compositions comprising said compounds, methods of treatment of diseases mediated by PKB using said compounds and methods for preparing compounds of Formula (I).

Abstract: Implementations generally relate to displaying a presenter during a video conference. In some implementations, a method includes providing a user interface of a video conference between at least a first user and a second user, where the first user is associated with a first endpoint and the second user is associated with a second endpoint. The method also includes determining view rank values for each of the first endpoint and the second endpoint. The method also includes causing the user interface to display a first user video stream in a current presenter position and to display a second user video stream in a secondary presenter position based on the view rank values.